BDAZ, KBC, thanks for the responses. What I was getting at was more along the lines of management hopefully being aware of the nature of the RRR when they are announcing it. For example, just picking numbers out of the air, if they were to announce that the RRR for the test group was 20% that could mean that the RRR was 20% in both the Apabetalone + rosuvastatin group and the Apabetalone + atorvastatin group or it could mean that the RRR was 40% in one of the groups and 0% in the other. If the overall RRR is a big number that will mean Apabetalone is a big success but a big number only in either subgroup will likely not diminish the success. It will be very interesting to see how this plays out.